摘要
目的观察新冠肺炎康复者恢复期血浆对青海重型、危重型患者疗效。方法采用新型冠状病毒肺炎(NCP)康复者恢复期血浆输入重型、危重型患者体内,每次50 mL,1次/2天,共输注2次,观察相关临床指标及疗效。结果 3例重型、危重型患者18天内好转出院。2~5天内临床症状好转,肺部影像学病灶逐渐吸收,治疗前后PCT、ALT、OI等差异具有统计学意义。结论恢复期血浆疗法效果显著。
Objective To observe the effects of plasma therapy in convalescence in the treatment of severe and critical COVID-19 patients in Qinghai. Methods The plasma from recovered COVID-19 patients were injected to severe and critical COVID-19 patients with 50 m L each time,once every 2 days,2 times in total to observe the relevant clinical indicators and curative effects. Results Three patients with severe or critical condition improved and were discharged within 18 days. The clinical symptoms improved within 2 ~ 5 days,and the pulmonary imaging lesions were gradually absorbed.There were statistically significant differences in PCT( procalcitonin,PCT),ALT( Alanine aminotransferase,ALT) and OI( oxygenation index,OI) before and after treatment. Conclusion The effects of convalescence plasma therapy in the COVID-19 patients are remarkable.
作者
卓玛
赵雪梅
杨正平
郗爱旗
丁月荷
戴景涛
王文明
余英芳
韵霞
ZHUO Ma;ZHAO Xuemei;YANG Zhengping;XI Aiqi;DING Yuehe;DAI Jingtao;WANG Wenming;YU Yingfang;YUN Xia(The Fourth People's Hospital of Qinghai Province,Xining 810007,China;People's Hospital of Qinghai,Xining 810000,China)
出处
《中国高原医学与生物学杂志》
CAS
2021年第1期13-18,共6页
Journal of Chinese High Altitude Medicine & Biology
基金
青海省科技厅科技成果转化专项项目(2020)。
关键词
新型冠状病毒肺炎患者
重型
危重型
康复期
血浆
应用
COVID-19 patients
severe type
critical type
convalescence
plasma therapy
application
